文献速递腹部技术与安全CT

双分裂扫描腹部CT中低剂量与超低剂量深度学习重建与标准剂量腹部CT图像质量的个体内比较

Intraindividual Comparison of Image Quality Between Low-Dose and Ultra-Low-Dose Abdominal CT With Deep Learning Reconstruction and Standard-Dose Abdominal CT Using Dual-Split Scan.
PubMed 文献 · Invest Radiol · 2025-01-28

前瞻性研究纳入133例疑似肝转移患者,采用双源CT双分裂扫描个体内比较低剂量(67%)和超低剂量(33%)深度学习重建与标准剂量(100%)模型迭代重建的图像质量。低剂量和超低剂量CT的辐射剂量显著低于标准剂量,肝局灶性病变显示度和检出率在非劣效界值内,但肝转移瘤敏感度低于标准剂量,特异度相似。

要点

  • 低剂量和超低剂量CT的辐射剂量显著低于标准剂量,肝局灶性病变显示度和检出率非劣效于标准剂量。
  • 低剂量和超低剂量CT对肝转移瘤的敏感度低于标准剂量,特异度相似。
  • 深度学习重建可用于低剂量和超低剂量腹部CT,但需注意转移瘤敏感度可能降低。

核心结论

  • 低剂量和超低剂量深度学习重建CT在肝局灶性病变显示度和检出率方面非劣效于标准剂量模型迭代重建CT,但肝转移瘤敏感度降低,需谨慎。

研究设计与样本

  • 前瞻性研究,纳入韩国2家三级医院133例疑似或已知肝转移患者,采用双源CT双分裂扫描,标准剂量按2:1分配至A管和B管(67%和33%),管电压根据体重指数选择100/120 kVp(<30 vs ≥30 kg/m²),标准剂量(100%)用模型迭代重建,低剂量(67%)和超低剂量(33%)用深度学习重建。

诊断标准与关键数值

  • 非劣效界值:显示度为-0.5,检出率为-0.1;肝转移瘤敏感度:标准剂量80.6%(95%CI 76.0, 84.5)vs 低剂量75.7%(95%CI 70.2, 80.5)vs 超低剂量73.7%(95%CI 68.3, 78.5),P<0.001;特异度相似(P>0.05)。

临床应用与阅片要点

  • 低剂量和超低剂量深度学习重建CT可用于评估肝局灶性病变,但需注意肝转移瘤敏感度可能降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to intraindividually compare the conspicuity of focal liver lesions (FLLs) between low- and ultra-low-dose computed tomography (CT) with deep learning reconstruction (DLR) and standard-dose CT with model-based iterative reconstruction (MBIR) from a single CT using dual-split scan in patients with suspected liver metastasis via a noninferiority design.

MATERIALS AND METHODS: This prospective study enrolled participants who met the eligibility criteria at 2 tertiary hospitals in South Korea from June 2022 to January 2023. The criteria included ( a ) being aged between 20 and 85 years and ( b ) having suspected or known liver metastases. Dual-source CT scans were conducted, with the standard radiation dose divided in a 2:1 ratio between tubes A and B (67% and 33%, respectively). The voltage settings of 100/120 kVp were selected based on the participant's body mass index (<30 vs ≥30 kg/m 2 ). For image reconstruction, MBIR was utilized for standard-dose (100%) images, whereas DLR was employed for both low-dose (67%) and ultra-low-dose (33%) images. Three radiologists independently evaluated FLL conspicuity, the probability of metastasis, and subjective image quality using a 5-point Likert scale, in addition to quantitative signal-to-noise and contrast-to-noise ratios. The noninferiority margins were set at -0.5 for conspicuity and -0.1 for detection.

RESULTS: One hundred thirty-three participants (male = 58, mean body mass index = 23.0 ± 3.4 kg/m 2 ) were included in the analysis. The low- and ultra-low- dose had a lower radiation dose than the standard-dose (median CT dose index volume: 3.75, 1.87 vs 5.62 mGy, respectively, in the arterial phase; 3.89, 1.95 vs 5.84 in the portal venous phase, P < 0.001 for all). Median FLL conspicuity was lower in the low- and ultra-low-dose scans compared with the standard-dose (3.0 [interquartile range, IQR: 2.0, 4.0], 3.0 [IQR: 1.0, 4.0] vs 3.0 [IQR: 2.0, 4.0] in the arterial phase; 4.0 [IQR: 1.0, 5.0], 3.0 [IQR: 1.0, 4.0] vs 4.0 [IQR: 2.0, 5.0] in the portal venous phases), yet within the noninferiority margin ( P < 0.001 for all). FLL detection was also lower but remained within the margin (lesion detection rate: 0.772 [95% confidence interval, CI: 0.727, 0.812], 0.754 [0.708, 0.795], respectively) compared with the standard-dose (0.810 [95% CI: 0.770, 0.844]). Sensitivity for liver metastasis differed between the standard- (80.6% [95% CI: 76.0, 84.5]), low-, and ultra-low-doses (75.7% [95% CI: 70.2, 80.5], 73.7 [95% CI: 68.3, 78.5], respectively, P < 0.001 for both), whereas specificity was similar ( P > 0.05).

CONCLUSIONS: Low- and ultra-low-dose CT with DLR showed noninferior FLL conspicuity and detection compared with standard-dose CT with MBIR. Caution is needed due to a potential decrease in sensitivity for metastasis ( clinicaltrials.gov/NCT05324046 ).

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Lee TY, Yoon JH, Park JY, et al. Intraindividual Comparison of Image Quality Between Low-Dose and Ultra-Low-Dose Abdominal CT With Deep Learning Reconstruction and Standard-Dose Abdominal CT Using Dual-Split Scan. Invest Radiol. 2025. PMID: 39874436. doi:10.1097/RLI.0000000000001151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。